Five Oceans Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Five Oceans Advisors's BMY Position: Q2 2026 in Review
Five Oceans Advisors reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, selling an estimated $9.24K and leaving 4,459 shares worth $257K. The position accounts for 0.08% of the portfolio, ranked #166.
Five Oceans Advisors first reported a position in BMY in Q3 2021 and has held it in 16 quarters since. The position peaked at $484K in Q2 2023. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Five Oceans Advisors held 4,459 shares of Bristol-Myers Squibb worth $257K as of Q2 2026.
- Five Oceans Advisors sold 161 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.24K.
- Bristol-Myers Squibb made up 0.08% of Five Oceans Advisors's portfolio in Q2 2026, its #166 holding.
- Five Oceans Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 16 quarters since.
- Five Oceans Advisors's Bristol-Myers Squibb position peaked at $484K in Q2 2023.
- 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.